Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma

Modern Pathology

Volumn 18, Issue 6, 2005, Pages 779-787

  Fukushima, Noriyoshi ^a   Koopmann, Jens ^a   Sato, Norihiro ^a   Prasad, Nijaguna ^a   Carvalho, Ralph ^a,b   Leach, Steven D ^a   Hruban, Ralph H ^a   Goggins, Michael ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Ductal adenocarcinoma; Gene expression; Pancreas; Parenchyma

Indexed keywords

GLYCOPROTEIN GP 39; PANCREATITIS ASSOCIATED PROTEIN; RNA; TUMOR MARKER;

ACINAR CELL; ADULT; AGED; ARTICLE; CANCER INFILTRATION; CELL LOSS; CHRONIC PANCREATITIS; CONTROLLED STUDY; DNA MICROARRAY; FIBROSIS; FROZEN SECTION; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LASER CAPTURE MICRODISSECTION; MAJOR CLINICAL STUDY; METAPLASIA; MORPHOLOGY; NUCLEOTIDE SEQUENCE; PANCREAS ADENOCARCINOMA; PARENCHYMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA HYBRIDIZATION; UNINDEXED SEQUENCE;

CARCINOMA, PANCREATIC DUCTAL; GENE EXPRESSION PROFILING; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LASERS; MICRODISSECTION; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREAS; PANCREATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM;

EID: 20344379456     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800337     Document Type: Article

References (23)

1. Klöppel GHR, Longnecker DS, Adler G, et al. Ductal adenocarcinoma of the pancreas. In: LA HSaA (ed). Pathology & Genetics, Tumours of the Digestive System, World Health Organization of Tumours. IARC Press: Lyon, 2000, pp 221-230.
2. Iacobuzio-Donahue CA, Ryu B, Hruban RH, et al. Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion. Am J Pathol 2002;160:91-99.
3. Sato N, Fukushima N, Maehara N, et al. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions. Oncogene 2003;22:5021-5030.
4. Frossard JL, Rubbia-Brandt L, Wallig MA, et al. Severe acute pancreatitis and reduced acinar cell apoptosis in the exocrine pancreas of mice deficient for the Cx32 gene. Gastroenterology 2003;124:481-493.
5. Ryu B, Jones J, Hollingsworth MA, et al. Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. Cancer Res 2001;61:1833-1838.
6. Rosty C, Christa L, Kuzdzal S, et al. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res 2002;62:1868-1875.
7. Costantini V, Zacharski LR, Memoli VA, et al. Fibrinogen deposition without thrombin generation in primary human breast cancer tissue. Cancer Res 1991;51:349-353.
8. Wojtukiewicz MZ, Rucinska M, Zacharski LR, et al. Localization of blood coagulation factors in situ in pancreatic carcinoma. Thromb Haemost 2001;86:1416-1420.
9. Preston T, Slater C, McMillan DC, et al. Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. J Nutr 1998;128:1355-1360.
10. Simpson-Haidaris PJ, Rybarczyk B. Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein. Ann NY Acad Sci 2001;936:406-425.
11. De Ceuninck F, Gaufillier S, Bonnaud A, et al. YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun 2001;285:926-931.
12. Malinda KM, Ponce L, Kleinman HK, et al. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res 1999;250:168-173.
13. Recklies AD, White C, Ling H. The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem J 2002;365:119-126.
14. Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, et al. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol 2002;160:1239-1249.
15. Koopmann JFN, Jain A, Maitra A, et al. Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2004;13:487-491.
16. Ward PP, Uribe-Luna S, Conneely OM. Lactoferrin and host defense. Biochem Cell Biol 2002;80:95-102.
17. Estevenon JP, Sarles H, Figarella C. Lactoferrin in the duodenal juice of patients with chronic calcifying pancreatitis. Scand J Gastroenterol 1975;10:327-330.
18. Hayakawa T, Harada H, Noda A, et al. Lactoferrin in pure pancreatic juice in chronic pancreatitis. Am J Gastroenterol 1983;78:222-224.
19. Hayakawa T, Naruse S, Kitagawa M, et al. Pancreatic stone protein and lactoferrin in human pancreatic juice in chronic pancreatitis. Pancreas 1995;10:137-142.
20. Okazaki K, Uchida K, Ghana M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 2000;118:573-581.
21. Tsuda H, Sekine K, Fujita K, et al. Cancer prevention by bovine lactoferrin and underlying mechanisms-a review of experimental and clinical studies. Biochem Cell Biol 2002;80:131-136.
22. Ushida Y, Sekine K, Kuhara T, et al. Possible chemopreventive effects of bovine lactoferrin on esophagus and lung carcinogenesis in the rat. Jpn J Cancer Res 1999;90:262-267.
23. Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003;98:1309-1314.